Calamos Advisors LLC Purchases Shares of 64,989 KORU Medical Systems, Inc. (NASDAQ:KRMD)

Calamos Advisors LLC purchased a new stake in KORU Medical Systems, Inc. (NASDAQ:KRMD) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 64,989 shares of the company’s stock, valued at approximately $250,000.

Several other institutional investors have also recently added to or reduced their stakes in the business. Empire Financial Management Company LLC acquired a new position in KORU Medical Systems in the third quarter valued at approximately $259,000. Geode Capital Management LLC lifted its stake in KORU Medical Systems by 6.5% in the third quarter. Geode Capital Management LLC now owns 462,128 shares of the company’s stock valued at $1,262,000 after buying an additional 28,323 shares during the period. XTX Topco Ltd acquired a new position in KORU Medical Systems in the third quarter valued at approximately $34,000. Finally, Connor Clark & Lunn Investment Management Ltd. lifted its stake in KORU Medical Systems by 77.7% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock valued at $168,000 after buying an additional 26,860 shares during the period. 58.60% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the company. Lake Street Capital boosted their price target on KORU Medical Systems from $4.00 to $5.00 and gave the company a “buy” rating in a research note on Tuesday, January 14th. Craig Hallum boosted their price objective on KORU Medical Systems from $5.00 to $6.00 and gave the company a “buy” rating in a report on Friday, January 17th. Piper Sandler boosted their price objective on KORU Medical Systems from $3.00 to $3.50 and gave the company an “overweight” rating in a report on Thursday, November 14th. Finally, Canaccord Genuity Group boosted their price objective on KORU Medical Systems from $3.00 to $4.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Four analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $4.50.

KORU Medical Systems Trading Up 6.5 %

Shares of KORU Medical Systems stock opened at $4.90 on Thursday. The stock has a fifty day simple moving average of $4.04 and a 200 day simple moving average of $3.12. KORU Medical Systems, Inc. has a 12-month low of $2.01 and a 12-month high of $5.05. The company has a market capitalization of $224.62 million, a P/E ratio of -19.60 and a beta of 0.45. The company has a current ratio of 2.99, a quick ratio of 2.37 and a debt-to-equity ratio of 0.01.

KORU Medical Systems Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.